日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.

硼替佐米和氯法拉滨联合治疗难治性肿瘤成人患者的 I 期试验。

Ahmed Jibran, DeSouza Andre, Kummar Shivaani, Rubinstein Lawrence, O'Sullivan-Coyne Geraldine, Govindharajulu Jeevan, Herrick William, Ferry-Galow Kate, Li Li, Wilsker Deborah F, Hogu Murielle, Piekarz Richard, Meehan Robert, Salkeni Mohamad Adham, Shin Sarah, Miller Brandon, Zlott Jennifer, Juwara Lamin, Gray Karen, Kuhlmann Laura, Srivastava Apurva, Parchment Ralph E, Doroshow James H, Takebe Naoko, Chen Alice P

A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors

尼洛替尼联合紫杉醇治疗晚期实体瘤患者的I期研究

Shin, Sarah J; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Miller, Sarah B; Johnson, Barry C; Anderson, Larry; Rubinstein, Larry; Miller, Brandon; Wilsker, Deborah F; Ferry-Galow, Katherine V; Piekarz, Richard; Zlott, Jennifer; Hogu, Murielle; Juwara, Lamin; Krushkal, Julia; Konaté, Mariam; Palmisano, Alida; Zhao, Yingdong; Collins, Jerry; Parchment, Ralph E; Doroshow, James H; Chen, Alice P

A phase 1 study of orally administered 5-fluoro-2'-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors

一项针对难治性实体瘤患者的口服5-氟-2'-脱氧胞苷联合四氢尿苷的I期研究

Chen, Alice P; Kummar, Shivaani; Rubinstein, Larry; Zlott, Jennifer; Coyne, Geraldine O'Sullivan; Chung, Vincent; Newman, Edward M; Lenz, Heinz-Josef; Kelly, Karen; Villaruz, Liza C; Konaté, Mariam M; Ferry-Galow, Katherine V; Wang, Lihua; Kinders, Robert J; Parchment, Ralph E; Covey, Joseph M; Holleran, Julianne L; Piekarz, Richard L; Miller, Sarah B; Juwara, Lamin; Beumer, Jan H; Doroshow, James H

Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors

PARP抑制剂他拉唑帕尼(MDV3800,BMN 673)在BRCA突变晚期实体瘤患者中的药效学作用

Mittra, Arjun; Coyne, Geraldine H O' Sullivan; Zlott, Jennifer; Kummar, Shivaani; Meehan, Robert; Rubinstein, Lawrence; Juwara, Lamin; Wilsker, Deborah; Ji, Jiuping; Miller, Brandon; Navas, Tony; Ferry-Galow, Katherine V; Voth, Andrea Regier; Chang, Ting-Chia; Jiwani, Shahanawaz; Parchment, Ralph E; Doroshow, James H; Chen, Alice P

Evaluating the indotecan-neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal E(max) regressions

通过群体药代动力学模型和S型E(max)回归评估实体瘤患者中吲哚替康与中性粒细胞减少症的关系

Beumer, Jan H; Kennard, Benjamin C; Holleran, Julianne L; Moore, Nancy; Zlott, Jennifer; Miller, Brian M; Kummar, Shivaani; Chen, Alice; Doroshow, James; Park, Wansu; Gobburu, Jogarao; Dunn, Allison

Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas

多受体酪氨酸激酶抑制剂卡博替尼 (XL184) 单药治疗难治性软组织肉瘤患者的临床活性

Geraldine O'Sullivan Coyne, Shivaani Kummar, James Hu, Kristen Ganjoo, Warren A Chow, Khanh T Do, Jennifer Zlott, Ashley Bruns, Lawrence Rubinstein, Jared C Foster, Lamin Juwara, Robert Meehan, Richard Piekarz, Howard Streicher, Elad Sharon, Naoko Takebe, Andrea Regier Voth, Donald Bottaro, Rene Cos

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

一项针对晚期实体瘤患者的每日一次 Wee1 抑制剂 Adavosertib (AZD1775) 的 I 期试验的安全性、抗肿瘤活性和生物标志物分析

Takebe, Naoko; Naqash, Abdul Rafeh; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Do, Khanh; Bruns, Ashley; Juwara, Lamin; Zlott, Jennifer; Rubinstein, Larry; Piekarz, Richard; Sharon, Elad; Streicher, Howard; Mittra, Arjun; Miller, Sarah B; Ji, Jiuping; Wilsker, Deborah; Kinders, Robert J; Parchment, Ralph E; Chen, Li; Chang, Ting-Chia; Das, Biswajit; Mugundu, Ganesh; Doroshow, James H; Chen, Alice P

Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors

静脉注射 5-氟-2'-脱氧胞苷与四氢尿苷联合使用可增加晚期实体瘤患者中表达 p16 的循环肿瘤细胞的比例

Geraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, Lamin Juwara, Joseph M Covey, Jan H Beumer, Mihaela C Cristea, Edward M Newman, Stephen Koehler, Jorge J Nieva, Agustin A Garcia, David R Gandara, Brandon Miller, Sonny Khin, Sarah B Miller, Seth M Steinberg, Larry Rubinstein, Ralph E Parchmen

Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas

TRC102(盐酸甲氧基胺)联合替莫唑胺治疗复发性实体瘤和淋巴瘤患者的I期临床试验

Coyne, Geraldine O'Sullivan; Kummar, Shivaani; Meehan, Robert S; Do, Khanh; Collins, Jerry M; Anderson, Larry; Ishii, Kazusa; Takebe, Naoko; Zlott, Jennifer; Juwara, Lamin; Piekarz, Richard; Streicher, Howard; Sharon, Elad; Rubinstein, Larry; Voth, Andrea Regier; Lozier, Jay; Dull, Angie B; Wilsker, Deborah; Hinoue, Toshinori; Laird, Peter W; Ferry-Galow, Katherine V; Kinders, Robert J; Parchment, Ralph E; Doroshow, James H; Chen, Alice P

A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas

Ganetespib 和 Ziv-Aflibercept 治疗晚期癌和肉瘤患者的 I 期研究

Meehan, Robert; Kummar, Shivaani; Do, Khanh; O'Sullivan Coyne, Geraldine; Juwara, Lamin; Zlott, Jennifer; Rubinstein, Larry; Doroshow, James H; Chen, Alice P